MedTrace Logo

The Hypertension in the Very Elderly Trial (HYVET)

NCT00122811 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4000

Last updated 2007-08-21

No results posted yet for this study

Summary

The purpose of this study is to assess the benefits and risks of treating very elderly (those aged 80 or older) individuals with hypertension.

Conditions

Interventions

DRUG

Indapamide SR 1.5mg; Perindopril 2-4mg

Sponsors & Collaborators

  • British Heart Foundation

    collaborator OTHER

  • Institut de Recherches Internationales Servier

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Christopher J Bulpitt, MD, FRCP · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-11-30
Completion
2008-10-31

Countries

  • Bulgaria
  • China
  • Finland
  • Romania
  • Russia
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00122811 on ClinicalTrials.gov